Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Elevated plasma ceramide levels in post-menopausal women: a cross-sectional study.

Vozella V, Basit A, Piras F, Realini N, Armirotti A, Bossù P, Assogna F, Sensi SL, Spalletta G, Piomelli D.

Aging (Albany NY). 2019 Jan 8;11(1):73-88. doi: 10.18632/aging.101719.

2.

Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?

van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Clark VP, Mueller BA, de Zwarte SMC, Ophoff RA, van Haren NEM, Andreassen OA, Gurholt TP, Gruber O, Kraemer B, Richter A, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Catts S, Fullerton JM, Green MJ, Henskens F, Jablensky A, Mowry BJ, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Hong E, Kochunov P, Gur RE, Gur RC, Ford JM, Macciardi F, Mathalon DH, Potkin SG, Preda A, Fan F, Ehrlich S, King MD, De Haan L, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, Pomarol-Clotet E, Kelly S, Ciufolini S, Radua J, Murray R, Marques TR, Simmons A, Borgwardt S, Schönborn-Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Yun JY, Cannon DM, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L; Karolinska Schizophrenia Project, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, McIntosh AM, Whalley HC, Knöchel C, Oertel-Knöchel V, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA.

Biol Psychiatry. 2018 Nov 20. pii: S0006-3223(18)31935-8. doi: 10.1016/j.biopsych.2018.10.003. [Epub ahead of print] No abstract available.

PMID:
30470561
3.

Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment.

Bossù P, Salani F, Ciaramella A, Sacchinelli E, Mosca A, Banaj N, Assogna F, Orfei MD, Caltagirone C, Gianni W, Spalletta G.

Front Aging Neurosci. 2018 Nov 2;10:285. doi: 10.3389/fnagi.2018.00285. eCollection 2018.

4.

Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial.

Antonini A, Gentile G, Giglio M, Marcante A, Gage H, Touray MML, Fotiadis DI, Gatsios D, Konitsiotis S, Timotijevic L, Egan B, Hodgkins C, Biundo R, Pellicano C; PD_Manager consortium.

Trials. 2018 Sep 14;19(1):492. doi: 10.1186/s13063-018-2767-4.

5.

Psychiatric profile of motor subtypes of de novo drug-naïve Parkinson's disease patients.

Assogna F, Pellicano C, Cravello L, Savini C, Pierantozzi M, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G, Stefani A.

Brain Behav. 2018 Oct;8(10):e01094. doi: 10.1002/brb3.1094. Epub 2018 Aug 30.

6.

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, Mueller BA, Cahn W, de Zwarte SMC, Hulshoff Pol HE, Kahn RS, Ophoff RA, van Haren NEM, Andreassen OA, Dale AM, Doan NT, Gurholt TP, Hartberg CB, Haukvik UK, Jørgensen KN, Lagerberg TV, Melle I, Westlye LT, Gruber O, Kraemer B, Richter A, Zilles D, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Carr VJ, Catts S, Cropley VL, Fullerton JM, Green MJ, Henskens FA, Jablensky A, Lenroot RK, Mowry BJ, Michie PT, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Morris DW, Hong E, Kochunov P, Beard LM, Gur RE, Gur RC, Satterthwaite TD, Wolf DH, Belger A, Brown GG, Ford JM, Macciardi F, Mathalon DH, O'Leary DS, Potkin SG, Preda A, Voyvodic J, Lim KO, McEwen S, Yang F, Tan Y, Tan S, Wang Z, Fan F, Chen J, Xiang H, Tang S, Guo H, Wan P, Wei D, Bockholt HJ, Ehrlich S, Wolthusen RPF, King MD, Shoemaker JM, Sponheim SR, De Haan L, Koenders L, Machielsen MW, van Amelsvoort T, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, McKenna PJ, Pomarol-Clotet E, Salvador R, Corvin A, Donohoe G, Kelly S, Whelan CD, Dickie EW, Rotenberg D, Voineskos AN, Ciufolini S, Radua J, Dazzan P, Murray R, Reis Marques T, Simmons A, Borgwardt S, Egloff L, Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Wang L, Jönsson EG, Koops S, Sommer IEC, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Stephen JM, Kwon JS, Yun JY, Cannon DM, McDonald C, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L; Karolinska Schizophrenia Project, Busatto GF, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, Hagenaars SP, McIntosh AM, Whalley HC, Lawrie SM, Knöchel C, Oertel-Knöchel V, Stäblein M, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, McMahon A, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA.

Biol Psychiatry. 2018 Nov 1;84(9):644-654. doi: 10.1016/j.biopsych.2018.04.023. Epub 2018 May 14.

7.

Influence of APOE and RNF219 on Behavioral and Cognitive Features of Female Patients Affected by Mild Cognitive Impairment or Alzheimer's Disease.

Mosca A, Sperduti S, Pop V, Ciavardelli D, Granzotto A, Punzi M, Stuppia L, Gatta V, Assogna F, Banaj N, Piras F, Piras F, Caltagirone C, Spalletta G, Sensi SL.

Front Aging Neurosci. 2018 Apr 13;10:92. doi: 10.3389/fnagi.2018.00092. eCollection 2018.

8.

Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates.

Orfei MD, Assogna F, Pellicano C, Pontieri FE, Caltagirone C, Pierantozzi M, Stefani A, Spalletta G.

Parkinsonism Relat Disord. 2018 Sep;54:62-67. doi: 10.1016/j.parkreldis.2018.04.015. Epub 2018 Apr 17.

PMID:
29709507
9.

Orthostatic hypotension acutely impairs executive functions in Parkinson's disease.

Sforza M, Assogna F, Rinaldi D, Sette G, Tagliente S, Pontieri FE.

Neurol Sci. 2018 Aug;39(8):1459-1462. doi: 10.1007/s10072-018-3394-2. Epub 2018 Apr 7.

PMID:
29627942
10.

Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.

Pellicano C, Assogna F, Cellupica N, Piras F, Pierantozzi M, Stefani A, Cerroni R, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G.

Parkinsonism Relat Disord. 2017 Dec;45:50-56. doi: 10.1016/j.parkreldis.2017.10.002. Epub 2017 Oct 6.

PMID:
29037499
11.

Rasagiline for dysexecutive symptoms during wearing-off in Parkinson's disease: a pilot study.

Rinaldi D, Assogna F, Sforza M, Tagliente S, Pontieri FE.

Neurol Sci. 2018 Jan;39(1):141-143. doi: 10.1007/s10072-017-3123-2. Epub 2017 Sep 27.

PMID:
28956175
12.

Alexithymia in Parkinson's disease: A systematic review of the literature.

Assogna F, Cravello L, Orfei MD, Cellupica N, Caltagirone C, Spalletta G.

Parkinsonism Relat Disord. 2016 Jul;28:1-11. doi: 10.1016/j.parkreldis.2016.03.021. Epub 2016 Mar 30. Review.

PMID:
27086264
13.

Dopaminergic system and dream recall: An MRI study in Parkinson's disease patients.

De Gennaro L, Lanteri O, Piras F, Scarpelli S, Assogna F, Ferrara M, Caltagirone C, Spalletta G.

Hum Brain Mapp. 2016 Mar;37(3):1136-47. doi: 10.1002/hbm.23095. Epub 2015 Dec 24.

PMID:
26704150
14.

On the relationship between side of onset and cognition in Parkinson disease: Response from the authors.

Pellicano C, Assogna F, Cravello L, Langella R, Caltagirone C, Spalletta G, Pontieri FE.

Parkinsonism Relat Disord. 2015 Dec;21(12):1481-2. doi: 10.1016/j.parkreldis.2015.10.005. Epub 2015 Oct 9. No abstract available.

PMID:
26476462
15.

Neuropsychiatric and cognitive symptoms and body side of onset of parkinsonism in unmedicated Parkinson's disease patients.

Pellicano C, Assogna F, Cravello L, Langella R, Caltagirone C, Spalletta G, Pontieri FE.

Parkinsonism Relat Disord. 2015 Sep;21(9):1096-100. doi: 10.1016/j.parkreldis.2015.07.002. Epub 2015 Jul 8.

PMID:
26173702
16.

Unraveling predictors affecting compliance to MRI in Parkinson's disease.

Cacciari C, Pellicano C, Cravello L, Assogna F, Piras F, Paravia P, Gili T, Iorio M, Stefani A, Pierantozzi M, Caltagirone C, Pontieri FE, Spalletta G.

Parkinsonism Relat Disord. 2015 Aug;21(8):964-7. doi: 10.1016/j.parkreldis.2015.05.009. Epub 2015 May 15.

PMID:
26025804
17.

Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson's disease.

Pontieri FE, Assogna F, Pellicano C, Cacciari C, Pannunzi S, Morrone A, Danese E, Caltagirone C, Spalletta G.

Eur Neuropsychopharmacol. 2015 Jan;25(1):69-76. doi: 10.1016/j.euroneuro.2014.11.006. Epub 2014 Nov 18.

PMID:
25435085
18.

Does a volume reduction of the parietal lobe contribute to freezing of gait in Parkinson's disease?

Rubino A, Assogna F, Piras F, Di Battista ME, Imperiale F, Chiapponi C, Spalletta G, Meco G.

Parkinsonism Relat Disord. 2014 Oct;20(10):1101-3. doi: 10.1016/j.parkreldis.2014.07.002. Epub 2014 Jul 29.

PMID:
25112926
19.

The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease.

Spalletta G, Robinson RG, Cravello L, Pontieri FE, Pierantozzi M, Stefani A, Long JD, Caltagirone C, Assogna F.

J Neurol. 2014 Jun;261(6):1126-32. doi: 10.1007/s00415-014-7327-6. Epub 2014 Apr 3.

PMID:
24695996
20.

Polygenic determinants of white matter volume derived from GWAS lack reproducibility in a replicate sample.

Papiol S, Mitjans M, Assogna F, Piras F, Hammer C, Caltagirone C, Arias B, Ehrenreich H, Spalletta G.

Transl Psychiatry. 2014 Feb 18;4:e362. doi: 10.1038/tp.2013.126.

Supplemental Content

Loading ...
Support Center